The AMFI m-cap reclassification rarely leads to predictable stock price changes, challenging the myth of price discovery.

Lybi Ma's new book combines evidence-based research with personal stories to demonstrate how we can achieve greater inner ...

Monthly real GDP is estimated to have grown by 0.3% in November 2025, following an unrevised fall of 0.1% in October 2025. Services and production both grew in November 2025, by 0.3% and 1.1%, ...

Small, unresolved patterns carry outsized emotional weight. Recognizing them early can change the course of connection and ...

The discovery that tissues use electricity to expel unhealthy cells is part of a surge of renewed interest in the currents ...

Nicole comforts Dani in her grief as Chelsea asks Bill to step in for support but Andre forbids him from stepping forward for ...

If you are confused by personal finance terms, jargon and calculations, here’s a series to simplify and deconstruct these for ...

Learn about the negative correlation coefficient, its significance, comparison with other coefficients, and real-world ...

Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic ...

The reasonable headline index return masks the fact that 2025 was a sombre year for most stocks, which should put the ...

Highlights in ER-positive breast cancer from SABCS 2025 include key metastatic and early-stage trial results from AMBRE, ...

China NMPA grants breakthrough therapy designation to Kelun-Biotech’s sacituzumab tirumotecan in combo with immunotherapy pembrolizumab for first-line treatment of PD-L1-positive NSCLC ...